blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2655321

EP2655321 - PURIFICATION OF PRECURSOR COMPOUND BY CRYSTALLISATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.12.2017
Database last updated on 13.07.2024
FormerThe patent has been granted
Status updated on  13.01.2017
FormerGrant of patent is intended
Status updated on  28.11.2016
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL, IS		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
GE Healthcare Limited
Amersham Place
Little Chalfont, Buckinghamshire HP7 9NA / GB
[2017/07]
Former [2013/44]For all designated states
GE Healthcare Limited
Amersham Place Little Chalfont
Buckinghamshire HP7 9NA / GB
Inventor(s)01 / NILSEN, Anne
GE HEALTHCARE AS
Nycoveien 2
Postboks 4220 Nydalen
N-0401 Oslo / NO
02 / NILSEN, Sondre
GE HEALTHCARE AS
Nycoveien 2
Postboks 4220 Nydalen
N-0401 Oslo / NO
 [2013/44]
Representative(s)Bannan, Sally, et al
GE Healthcare Limited
Intellectual Property
Pollards Wood
Nightingales Lane
Chalfont St.Giles Buckinghamshire HP8 4SP / GB
[2017/07]
Former [2013/44]Bannan, Sally, et al
GE Healthcare Limited
Intellectual Property
Pollards Wood
Nightingales Lane, Chalfont St Giles
Buckinghamshire HP8 4SP / GB
Application number, filing date11802373.819.12.2011
[2017/07]
WO2011EP73247
Priority number, dateGB2010002153020.12.2010         Original published format: GB 201021530
US201061424695P20.12.2010         Original published format: US 201061424695 P
[2013/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012084831
Date:28.06.2012
Language:EN
[2012/26]
Type: A1 Application with search report 
No.:EP2655321
Date:30.10.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 28.06.2012 takes the place of the publication of the European patent application.
[2013/44]
Type: B1 Patent specification 
No.:EP2655321
Date:15.02.2017
Language:EN
[2017/07]
Search report(s)International search report - published on:EP28.06.2012
ClassificationIPC:C07C227/20, C07C269/06, C07B59/00, C07C303/28, C07C271/24, C07C309/65, C07C309/73
[2016/27]
CPC:
C07C227/20 (EP,CN); C07B59/001 (EP,CN,RU); C07C269/06 (EP,CN,KR,RU);
C07C303/28 (EP,CN,KR,RU); C07C227/18 (RU); C07C271/24 (KR);
C07C309/65 (KR); C07C309/73 (KR); C07B2200/05 (EP,CN);
C07C2601/04 (EP); Y02P20/55 (EP) (-)
C-Set:
C07C227/20, C07C229/48 (CN,EP);
C07C269/06, C07C271/24 (CN,EP);
C07C303/28, C07C309/65 (CN,EP);
C07C303/28, C07C309/73 (EP)
Former IPC [2013/44]C07C269/06, C07B59/00, C07C303/28, C07C271/24, C07C309/65, C07C309/73
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/44]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:REINIGUNG VON VORLÄUFERVERBINDUNGEN DURCH KRISTALLISATION[2013/44]
English:PURIFICATION OF PRECURSOR COMPOUND BY CRYSTALLISATION[2013/44]
French:PURIFICATION DE COMPOSÉ PRÉCURSEUR PAR CRISTALLISATION[2013/44]
Entry into regional phase06.06.2013National basic fee paid 
06.06.2013Designation fee(s) paid 
06.06.2013Examination fee paid 
Examination procedure06.06.2013Amendment by applicant (claims and/or description)
06.06.2013Examination requested  [2013/44]
22.10.2015Despatch of a communication from the examining division (Time limit: M04)
01.03.2016Reply to a communication from the examining division
15.07.2016Communication of intention to grant the patent
24.11.2016Fee for grant paid
24.11.2016Fee for publishing/printing paid
24.11.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  22.10.2015
Opposition(s)16.11.2017No opposition filed within time limit [2018/04]
Fees paidRenewal fee
27.03.2014Renewal fee patent year 03
29.12.2014Renewal fee patent year 04
28.12.2015Renewal fee patent year 05
27.12.2016Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.12.201303   M06   Fee paid on   27.03.2014
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU19.12.2011
AL15.02.2017
AT15.02.2017
CY15.02.2017
CZ15.02.2017
FI15.02.2017
HR15.02.2017
LT15.02.2017
LV15.02.2017
MC15.02.2017
MK15.02.2017
NL15.02.2017
PL15.02.2017
RO15.02.2017
RS15.02.2017
SE15.02.2017
SI15.02.2017
SK15.02.2017
SM15.02.2017
TR15.02.2017
BG15.05.2017
GR16.05.2017
IS15.06.2017
PT15.06.2017
[2020/33]
Former [2020/15]HU19.12.2011
AT15.02.2017
CY15.02.2017
CZ15.02.2017
FI15.02.2017
HR15.02.2017
LT15.02.2017
LV15.02.2017
MC15.02.2017
MK15.02.2017
NL15.02.2017
PL15.02.2017
RO15.02.2017
RS15.02.2017
SE15.02.2017
SI15.02.2017
SK15.02.2017
SM15.02.2017
TR15.02.2017
BG15.05.2017
GR16.05.2017
PT15.06.2017
Former [2019/51]HU19.12.2011
AT15.02.2017
CY15.02.2017
CZ15.02.2017
FI15.02.2017
HR15.02.2017
LT15.02.2017
LV15.02.2017
MC15.02.2017
MK15.02.2017
NL15.02.2017
PL15.02.2017
RO15.02.2017
RS15.02.2017
SE15.02.2017
SI15.02.2017
SK15.02.2017
SM15.02.2017
BG15.05.2017
GR16.05.2017
PT15.06.2017
Former [2019/46]HU19.12.2011
AT15.02.2017
CY15.02.2017
CZ15.02.2017
FI15.02.2017
HR15.02.2017
LT15.02.2017
LV15.02.2017
MC15.02.2017
NL15.02.2017
PL15.02.2017
RO15.02.2017
RS15.02.2017
SE15.02.2017
SI15.02.2017
SK15.02.2017
SM15.02.2017
BG15.05.2017
GR16.05.2017
PT15.06.2017
Former [2019/31]HU19.12.2011
AT15.02.2017
CZ15.02.2017
FI15.02.2017
HR15.02.2017
LT15.02.2017
LV15.02.2017
MC15.02.2017
NL15.02.2017
PL15.02.2017
RO15.02.2017
RS15.02.2017
SE15.02.2017
SI15.02.2017
SK15.02.2017
SM15.02.2017
BG15.05.2017
GR16.05.2017
PT15.06.2017
Former [2019/30]AT15.02.2017
CZ15.02.2017
FI15.02.2017
HR15.02.2017
LT15.02.2017
LV15.02.2017
MC15.02.2017
NL15.02.2017
PL15.02.2017
RO15.02.2017
RS15.02.2017
SE15.02.2017
SI15.02.2017
SK15.02.2017
SM15.02.2017
BG15.05.2017
GR16.05.2017
PT15.06.2017
Former [2018/14]AT15.02.2017
CZ15.02.2017
FI15.02.2017
HR15.02.2017
LT15.02.2017
LV15.02.2017
NL15.02.2017
PL15.02.2017
RO15.02.2017
RS15.02.2017
SE15.02.2017
SI15.02.2017
SK15.02.2017
SM15.02.2017
BG15.05.2017
GR16.05.2017
PT15.06.2017
Former [2017/51]AT15.02.2017
CZ15.02.2017
FI15.02.2017
HR15.02.2017
LT15.02.2017
LV15.02.2017
NL15.02.2017
PL15.02.2017
RO15.02.2017
RS15.02.2017
SE15.02.2017
SK15.02.2017
SM15.02.2017
BG15.05.2017
GR16.05.2017
PT15.06.2017
Former [2017/49]AT15.02.2017
CZ15.02.2017
FI15.02.2017
HR15.02.2017
LT15.02.2017
LV15.02.2017
NL15.02.2017
RO15.02.2017
RS15.02.2017
SE15.02.2017
SK15.02.2017
BG15.05.2017
GR16.05.2017
PT15.06.2017
Former [2017/48]AT15.02.2017
CZ15.02.2017
FI15.02.2017
HR15.02.2017
LT15.02.2017
LV15.02.2017
NL15.02.2017
RS15.02.2017
SE15.02.2017
BG15.05.2017
GR16.05.2017
PT15.06.2017
Former [2017/41]AT15.02.2017
FI15.02.2017
HR15.02.2017
LT15.02.2017
LV15.02.2017
NL15.02.2017
RS15.02.2017
SE15.02.2017
BG15.05.2017
GR16.05.2017
PT15.06.2017
Cited inInternational search[ID]EP1978015  (NIHON MEDIPHYSICS CO LTD [JP]) [ID] 1-19 * the whole document *;
 [A]EP2230229  (NIHON MEDIPHYSICS CO LTD [JP]) [A] 1-19 * example - *;
 [A]  - WANG L J ET AL, "Syntheses of new conformationally constrained S-Ä2-Ä(1-iminoethyl)aminoÜ ethylÜhomocysteine derivatives as potential nitric oxide synthase inhibitors", HETEROATOM CHEMISTRY, VCH PUBLISHERS, DERFIELD BEACH, FL, US, (20020101), vol. 13, no. 1, doi:10.1002/HC.1109, ISSN 1042-7163, pages 77 - 83, XP003013677 [A] 1-10 * Scheme 1; page 80, column l, paragraph l - page 80, column r, paragraph 2 *

DOI:   http://dx.doi.org/10.1002/hc.1109
by applicantEP1978015
    - Handbook of Radiopharmaceuticals, (2003), pages 195 - 227
    - MCCONATHY ET AL., APPL RADIAT ISOTOP, (2003), vol. 58, pages 657 - 666
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.